ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus

Liu, Shu-Yuan; Xu, Sheng-Yong; Yin, Lu; Yang, Ting; Jin, Kui; Zhang, Qiu-Bin; Sun, Feng; Tan, Ding-Yu; Xin, Tian-Yu; Chen, Yu-Guo; Zhao, Xiao-Dong; Yu, Xue-Zhong; Xu, Jun; Chen, Xu-Feng; Chen, Yu-Guo; Chen, Zhi; Dou, Qing-Li; Guan, Jian; Gui, Yao-Song; Huang, Zhong-Wei; Jin, Kui; Li, Xiao-Min; Liu, Dan-Ping; Liu, Shu-Yuan; Lv, Jing-Jun; Liu, Yong; Qian, Chuan-Yun; Shan, Yi; Shi, Yan; Sun, Feng; Sun, Ming; Tan, Ding-Yu; Wu, Hai-Ying; Xia, Jian; Xin, Tian-Yu; Xu, Feng; Xu, Jun; Xu, Sheng-Yong北京大学; 南方医科大学; 南通大学; 清华大学; 山东大学; 海南医学院; 浙江大学; 武汉大学; 中国医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 6; 1
Military Medical Research2023-5-29DOI: 10.1186/s40779-023-00457-9
2被引31阅读
引用收藏
分享

摘要

Continuous renal replacement therapy (CRRT) is widely used for treating critically-ill patients in the emergency department in China. Anticoagulant therapy is needed to prevent clotting in the extracorporeal circulation during CRRT. Regional citrate anticoagulation (RCA) has been shown to potentially be safer and more effective and is now recommended as the preferred anticoagulant method for CRRT. However, there is still a lack of unified standards for RCA management in the world, and there are many problems in using this method in clinical practice. The Emergency Medical Doctor Branch of the Chinese Medical Doctor Association (CMDA) organized a panel of domestic emergency medicine experts and international experts of CRRT to discuss RCA-related issues, including the advantages and disadvantages of RCA in CRRT anticoagulation, the principle of RCA, parameter settings for RCA, monitoring of RCA (mainly metabolic acid-base disorders), and special issues during RCA. Based on the latest available research evidence as well as the paneled experts' clinical experience, considering the generalizability, suitability, and potential resource utilization, while also balancing clinical advantages and disadvantages, a total of 16 guideline recommendations were formed from the experts' consensus.

学科与关键词

关键词
Continuous renal replacement therapyEmergencyAnticoagulationCitrateGuidelineExpert consensus
相关
加载中…
  • Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury
    Wen Xiong, Li; De Lin, Liu; Li Feng, Huang; Wen Liang, Ma; Qi, Ding; Yue, Han; Yue, ZhengChinese Medical Journal, 2016, 129(14): 1682.
  • Continuous Renal-Replacement Therapy in Critically Ill Children: Practice Changes and Association With Outcome
    Chen, ZhiJiang; Wang, HuiLi; Wu, Zhu; Jin, Ming; Chen, YiTing; Li, Jun; Wei, QiuJu; Tao, ShaoHua*; Zeng, Qiyi*Pediatric Critical Care Medicine, 2021, 22(12): E605-E612.被引 4
  • Plasma Metformin Levels at Almost 24 Hours Would Help With the Delicate Decision to Start Renal Replacement Therapy: We Disagree as Lactate That Is More Widely and Early Available Should Be a Much Better Trigger to Start Renal Replacement Therapy!
    Patrick M., Honore; Sebastien, Redant; Keitiane, Kaefer; Luc, Kugener; Leonel, Barreto Gutierrez; Rachid, Attou; Andrea, Gallerani; David, De BelsCritical Care Medicine, 2021, 49(4): e463-e464.
查看全部 →

发表信息

论文状态
公开发表
期刊
Military Medical Research
发表日期
2023-05-29
卷期
第 10 卷, 第 1 期
页码
23
DOI
10.1186/s40779-023-00457-9
期刊收录
CAST-E
成果收录
SCIE

作者

  • L

    Liu, Shu-Yuan (第一作者)

  • X

    Xu, Sheng-Yong

查看全部 58 位作者收起作者
  • Y

    Yin, Lu

  • Y

    Yang, Ting

  • J

    Jin, Kui

  • Z

    Zhang, Qiu-Bin

  • S

    Sun, Feng

  • T

    Tan, Ding-Yu

  • X

    Xin, Tian-Yu

  • C

    Chen, Yu-Guo

  • Z

    Zhao, Xiao-Dong

  • Y

    Yu, Xue-Zhong

  • X

    Xu, Jun

  • C

    Chen, Xu-Feng

  • C

    Chen, Yu-Guo

  • C

    Chen, Zhi

    jiangxi prov peoples hosp

  • D

    Dou, Qing-Li

    2 · shenzhen univ

  • G

    Guan, Jian

    tsinghua univ

  • G

    Gui, Yao-Song

  • H

    Huang, Zhong-Wei

    nantong univ

  • J

    Jin, Kui

  • L

    Li, Xiao-Min

  • L

    Liu, Dan-Ping

  • L

    Liu, Shu-Yuan

  • L

    Lv, Jing-Jun

    wuhan univ

  • L

    Liu, Yong

    southern med univ

  • Q

    Qian, Chuan-Yun

  • S

    Shan, Yi

  • S

    Shi, Yan

  • S

    Sun, Feng

  • S

    Sun, Ming

    xuzhou med univ

  • T

    Tan, Ding-Yu

  • W

    Wu, Hai-Ying

  • X

    Xia, Jian

    wuhan univ

  • X

    Xin, Tian-Yu

  • X

    Xu, Feng

  • X

    Xu, Jun

  • X

    Xu, Sheng-Yong

  • X

    Xu, Tie

    xuzhou med univ

  • Y

    Yan, Xian-Liang

  • Y

    Yang, Jian-Zhong

    1 · xinjiang med univ

  • Y

    Yang, Ting

  • Y

    Yin, Lu

  • Y

    Yu, Xue-Zhong

  • Y

    Yu, Yong-Wu

    beijing chuiyangliu hosp

  • Z

    Zhang, Jin-Song

  • Z

    Zhang, Mao

    2 · zhejiang univ

  • Z

    Zhang, Qiu-Bin

  • Z

    Zhang, Wei

  • Z

    Zhao, Hong-Yu

    china med univ

  • Z

    Zhao, Xiao-Dong

  • Z

    Zheng, Dong-Hui

  • Z

    Zhou, Ping

    sichuan prov peoples hosp

  • Z

    Zhu, Bao-Feng

  • Z

    Zhu, Hua-Dong

  • S

    Shen, Shi-Qian

  • P

    Prowle, John

  • B

    Bellgardt, Martin

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417